Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube

Gynecologic Oncology

Volumn 118, Issue 3, 2010, Pages 299-302

  Vicus, Danielle ^a,b   Finch, Amy ^a   Cass, Ilana ^c   Rosen, Barry ^b   Murphy, Joan ^b   Fan, Isabel ^d   Royer, Robert ^a   McLaughlin, John ^d,e   Karlan, Beth ^c   Narod, Steven A ^a  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e CANCER CARE ONTARIO   (Canada)

Author keywords

BRCA mutation; Fallopian tube cancer; Prevalence

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER REGISTRY; CONTROLLED STUDY; ETHNICITY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; JEW; MAJOR CLINICAL STUDY; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; UTERINE TUBE CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; FALLOPIAN TUBE NEOPLASMS; FAMILY HEALTH; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; PREVALENCE;

EID: 77955553054     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.05.011     Document Type: Article

References (18)

1. P. Tonin, R. Moslehi, R. Green, B. Rosen, D. Cole, and N. Boyd Linkage analysis of 26 Canadian breast and breast-ovarian cancer families Hum Genet 95 1995 545 550
2. L.S. Friedman, C.I. Szabo, E.A. Ostermeyer, P. Dowd, L. Butler, and T. Park Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families Am J Hum Genet 57 1995 1284 1297
3. T.J. Colgan, J. Murphy, D.E. Cole, S. Narod, and B. Rosen Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status Am J Surg Pathol 25 2001 1283 1289
4. P.J. Paley, E.M. Swisher, R.L. Garcia, S.N. Agoff, B.E. Greer, and K.L. Peters Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis Gynecol Oncol 80 2001 176 180
5. A. Finch, P. Shaw, B. Rosen, J. Murphy, S.A. Narod, and T.J. Colgan Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers Gynecol Oncol 100 2006 58 64
6. C.B. Powell, E. Kenley, L.M. Chen, B. Crawford, J. McLennan, and C. Zaloudek Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J Clin Oncol 23 2005 127 132
7. M.L. Carcangiu, B. Peissel, B. Pasini, G. Spatti, P. Radice, and S. Manoukian Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature Am J Surg Pathol 30 2006 1222 1230
8. S. Aziz, G. Kuperstein, B. Rosen, D. Cole, R. Nedelcu, and J. McLaughlin A genetic epidemiological study of carcinoma of the fallopian tube Gynecol Oncol 80 2001 341 345
9. H.A. Risch, J.R. McLaughlin, D.E. Cole, B. Rosen, L. Bradley, and E. Kwan Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am J Hum Genet 68 2001 700 710
10. D. Abeliovich, L. Kaduri, I. Lerer, N. Weinberg, G. Amir, and M. Sagi The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women Am J Hum Genet 60 1997 505 514
11. N. Puget, O.M. Sinilnikova, D. Stoppa-Lyonnet, C. Audoynaud, S. Pages, and H.T. Lynch An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am J Hum Genet 64 1999 300 302
12. P.N. Tonin, A.M. Mes-Masson, P.A. Futreal, K. Morgan, M. Mahon, and W.D. Foulkes Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families Am J Hum Genet 63 1998 1341 1351
13. B. Newman, R.C. Millikan, and M.C. King Genetic epidemiology of breast and ovarian cancers Epidemiol Rev 19 1997 69 79
14. D. Ford, D.F. Easton, and J. Peto Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence Am J Hum Genet 57 1995 1457 1462
15. F. Medeiros, M.G. Muto, Y. Lee, J.A. Elvin, M.J. Callahan, and C. Feltmate The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2006 230 236
16. D.S. Tan, C. Rothermundt, K. Thomas, E. Bancroft, R. Eeles, and S. Shanley "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations J Clin Oncol 26 2008 5530 5536
17. I. Cass, R.L. Baldwin, T. Varkey, R. Moslehi, S.A. Narod, and B.Y. Karlan Improved survival in women with BRCA-associated ovarian carcinoma Cancer 97 2003 2187 2195
18. J. Boyd, Y. Sonoda, M.G. Federici, F. Bogomolniy, E. Rhei, and D.L. Maresco Clinicopathologic features of BRCA-linked and sporadic ovarian cancer JAMA 283 2000 2260 2265